Isracann Biosciences Company Top Insiders

Isracann Biosciences Management Team Effectiveness

The company has return on total asset (ROA) of (0.3499) % which means that it has lost $0.3499 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (2.5275) %, meaning that it generated substantial loss on money invested by shareholders. Isracann Biosciences' management efficiency ratios could be used to measure how well Isracann Biosciences manages its routine affairs as well as how well it operates its assets and liabilities.

Isracann Biosciences Workforce Comparison

Isracann Biosciences Benchmark Summation

Isracann Biosciences Notable Stakeholders

The success or failure of an entity such as Isracann Biosciences often depends on how effective the management is. Isracann Biosciences management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Isracann management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Isracann management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

When running Isracann Biosciences' price analysis, check to measure Isracann Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Isracann Biosciences is operating at the current time. Most of Isracann Biosciences' value examination focuses on studying past and present price action to predict the probability of Isracann Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Isracann Biosciences' price. Additionally, you may evaluate how the addition of Isracann Biosciences to your portfolios can decrease your overall portfolio volatility.